European Cardiology Review (ECR) is a PubMed indexed, peer-reviewed tri-annual journal comprising review articles, editorials and case reports. It features balanced and comprehensive articles written by leading authorities, addressing the most important and salient developments in cardiovascular medicine and practice.
Led by Editor-in-Chief Juan Carlos Kaski, supported by Associate Editors, and underpinned by an editorial board of world-renowned physicians, ECR is comprised of peer-reviewed articles that aim to provide timely updates on the most pertinent cardiology issues.
For information on submitting an article, please contact Ashlynne Merrifield, Managing Editor, firstname.lastname@example.org.
Frequency: Three print issues per year (Spring, Summer, Autumn); ePub ahead of print throughout the year.
Print ISSN: 1758-3756
Online ISSN: 1758-3764
Aims and Scope
ECR aims to assist time-pressured physicians to stay abreast of key advances and opinion in cardiology medicine and practice. The journal comprises balanced and comprehensive articles written by leading authorities, addressing the most pertinent developments in the field.
ECR provides comprehensive updates on a range of salient issues to support physicians in continuously developing their knowledge and effectiveness in day-to-day clinical practice.
Structure and Format
ECR is a tri-annual journal comprising review articles, editorials and case reports.
The structure and degree of coverage assigned to each category of the journal is the decision of the Editor-in-Chief, with the support of the Associate Editors and the Editorial Board.
ECR is guided by overall direction from an Editor-in-Chief, supported by the Associate Editors and an Editorial Board comprising leading authorities from a variety of related disciplines.
The journal’s contributors are recognised authorities in their respective fields.
Peer review is conducted by experts appointed for their experience and knowledge of a specific topic.
ECR is produced by an experienced team of Editors and Technical Editors.
On submission, all articles are assessed by the Editor-in-Chief to determine their suitability for inclusion.
The Managing Editor, following consultation with the Editor-in-Chief and/or a member of the Editorial Board, sends the manuscript to reviewers who are selected on the basis of their specialist knowledge in the relevant area. All peer review is conducted double-blind.
Following review, manuscripts are accepted without modification, accepted pending modification (in which case the manuscripts are returned to the author(s) to incorporate required changes), or rejected outright. The Editor-in-Chief reserves the right to accept or reject any proposed amendments.
Once the authors have amended a manuscript in accordance with the reviewers comments, the manuscript is assessed to ensure the revised version meets quality expectations. The manuscript is sent to the Editor-in-Chief for final approval prior to publication.
Submissions and Instructions to Authors
Contributors are identified by the Editor-in-Chief with the support of the Editorial Board and Managing Editor.
Following acceptance of an invitation, the author(s) and Managing Editor, in conjunction with the Editor-in-Chief, formalise the working title and scope of the article.
Our funding model
Radcliffe Cardiology provides free educational content to cardiologists and allied healthcare professionals. The vast majority of our content is editorially independent, developed at our own cost.
However, to keep the platform a free resource, from time-to-time we do collaborate and receive funding from select industry partners in the following ways and all sources of such funding are fully declared on all these materials:
- Print and ebook adverts at the front and back of the journals (never within the journal text)
- Web banner advertising
- Interstitial adverts
- Pre-roll video adverts (as pre-cursors to our independent content)
- Promotional/supplemental content (published as supplements to our peer-reviewed journals)
- Supported webinars, roundtable discussions, video interviews and live cases
- Continuing medical education activities
To support open access publication costs, Radcliffe Cardiology charges an Article Publication Charge (APC) to authors upon acceptance of an unsolicited paper as follows: £1,050 UK | €1,200 Eurozone | $1,369 all other countries.
(Submissions from the UK will be subject to the current UK VAT charge. A VAT registration number should be supplied to ensure any invoice accounts for VAT at your local relevant rate. Those not registered for VAT will have VAT added.)
APC Waivers and Discounts
A 100% waiver is available for all papers which are solicited directly from Radcliffe Cardiology.
Authors from low-income countries as defined by the World Bank are eligible for a full waiver of the APC charge. Authors from middle-income countries are eligible for a 50% waiver. Discretionary waivers may also be considered.
Radcliffe Cardiology remains dedicated to helping researchers to disseminate scientific information globally and is actively working to partner with individual institutions to offer full or partial APC discounts. Institutional agreements will be listed here. If you are an institution looking to partner with us, or think your institution should, please contact the Publishing Director.
To ensure editorial integrity, the waiver process is not handled by the journal Managing Editors. Authors should submit a waiver request during the electronic submission process.
All articles published in ECR are available as reprints (minimum order 1,000). Please contact Rob Barclay at email@example.com.
Distribution and Readership
ECR is distributed bi-annually through controlled circulation to senior healthcare professionals in the field in Europe.
Copyright and Permission
Radcliffe Cardiology is the sole owner of all articles and other materials that appear in European Cardiology Review unless otherwise stated. Permission to reproduce an article, either in full or in part, should be sought from the publication’s Managing Editor.